What We're Reading: Page 249
Industry reads hand-picked by our editors
Jul 26, 2018
-
The Washington Post
Pregnant women took generic Viagra in a clinical drug trial. Eleven babies died.
-
The Hill
Senate panel approves bill banning 'gag clauses' in pharmacy contracts
-
Kaiser Health News
How soon is soon enough to learn you have Alzheimer’s?
-
STAT
Zika's destructive power might be turned against tumors, scientists say
Jul 25, 2018
-
Bloomberg
The next cancer drug might start in outer space
-
Nature
Malaria’s ticking time bomb
-
The Wall Street Journal
As bosses leave, boards need to make succession plans
-
Wired
Making personalized cancer vaccines takes an army — of robots
Jul 24, 2018
-
Stat
Preclinical biotech companies are having an IPO bonanza. What's the draw for investors?
-
Boston Business Journal
Harvard, Stanford geneticists launch Arc Bio to fight drug-resistant diseases
-
Forbes
Precision medicine success hinges on diagnostics' clinical utility
-
The Wall Street Journal
Highflying medical firm, a help to wounded veterans, falls to Earth
Jul 23, 2018
Jul 20, 2018
-
Los Angeles Times
Big Pharma is quietly using nonprofits to push opioids
-
The Wall Street Journal
New York gives $25 million to breathe life into city’s biotech scene
-
Kaiser Health News
Long waits to see doctors in Puerto Rico, where medical needs are great post-Maria
-
CNBC
Approval of drug derived from cannabis not necessarily a win for weed
-
Science
On a remote Pacific island, this doctor has revived a 60-year quest to eradicate a disfiguring disease
Jul 19, 2018
Jul 18, 2018
-
FierceBiotech
For 2 biotech employees, coming out as trans means asking others to transition with them
-
CNN
Are 'breakthrough' drugs as safe as other FDA-approved medicines?
-
Kaiser Health News
Staggering prices slow insurers’ coverage of CAR-T cancer therapy
-
The Wall Street Journal
Biotech IPO boom comes with side effects
Previous
